Target intelligence / Profile preview

Influenza virus hemagglutinin stem (HA stem)

Target
HA stem
Molecular classification
Viral glycoprotein, Viral fusion protein, Other
01

Overview

The influenza virus hemagglutinin (HA) stem (or stalk) is a highly conserved region of the viral surface glycoprotein hemagglutinin, which plays a critical role in viral entry and infection. Unlike the highly variable globular head of HA, which is subject to rapid antigenic drift, the stem region remains relatively unchanged across diverse influenza strains and subtypes. This high conservation makes the HA stem a premier target for the development of broadly neutralizing antibodies (bnAbs), small-molecule fusion inhibitors, and universal influenza vaccines.

Therapeutic agents targeting the HA stem, such as the monoclonal antibodies MEDI8852, VIS410, and VIR-2482, or small molecules like JNJ-4796, function primarily by binding to the stem and locking it in its prefusion conformation. This blocks the low pH-induced conformational changes required for the fusion of the viral envelope with the host endosomal membrane, thereby preventing viral genome release into the host cell. Additionally, stem-binding antibodies can recruit host immune cells to eliminate infected cells via Fc-mediated effector functions like antibody-dependent cellular cytotoxicity (ADCC). Despite their preclinical promise, several stem-targeting candidates have faced challenges in clinical trials, including limited mucosal penetration and a lack of robust clinical efficacy, highlighting the ongoing need for optimized delivery and design.

Other names
Influenza virus hemagglutinin stalkHemagglutinin stem regionHemagglutinin stalk regionHA stemHA stalkInfluenza virus hemagglutinin stem conserved epitopes
02

Mechanism of action

Inhibition of viral membrane fusion by preventing low pH-induced conformational changes of hemagglutinin, and recruitment of Fc-mediated effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP).

03

Biological functions

Viral entryMembrane fusionImmune responseOther
04

Disease associations

InfectionOther
05

Safety considerations

Development of escape mutants (viral resistance)Antibody-dependent enhancement (ADE) of infectionInfusion-related reactionsLack of clinical efficacy due to poor mucosal tissue penetrationLow immunogenicity of the stem region compared to the immunodominant head regionPotential autoreactivity due to molecular mimicry with host proteins (e.g., EDC3)
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Stem-specific IgG antibody titerMicroneutralization assay titerViral loadHA stem-binding antibody levels

Beyond the preview

Go deeper on Influenza virus hemagglutinin stem (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus hemagglutinin stem (HA stem).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call